Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®
BioReference team is now able to provide the entire OvaSuite portfolio to healthcare providers in New York and New Jersey AUSTIN, Texas, Nov. 07, 2024 — Aspira Women’s Health Inc. , a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools,